Eurofins Scientific SE (ENXTPA: ERF)
Health Care · Life Sciences Tools & Services · LU
€72.82
-1.70% today · +11.1% 1Y
Eurofins Scientific SE (ENXTPA: ERF) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $14.73B and employs 65,000 people.
Over the last twelve months the share price has gained 11.1%, trading between 54.86 and 74.62.
Tweenvest scores Eurofins Scientific SE across four factors: quality 67/100, value 45/100, growth 69/100, dividend 67/100. Its strongest factor is growth.
ERF price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.73B
- Revenue (TTM)
- $8.44B
- P/E
- 28.47
- EPS
- 2.56
- Dividend yield
- 0.97%
- Beta (5Y)
- 0.84
- 52-week high
- €74.62
- 52-week low
- €54.86
- Avg volume (3M)
- —
- Shares outstanding
- 173.60M
- Employees
- 65,000
- Next earnings
- —
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
- ISIN
- FR0014000MR3
- Founded
- 1987
- Listed since
- Oct 24, 1997
- Exchange
- Euronext Paris
- Currency
- EUR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $234.31B | $633.71 | +0.89% |
| Danaher CorporationNYSE: DHR | $151.40B | $215.36 | -0.28% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $70.42B | CN¥159.25 | -1.09% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $50.96B | CHF587.80 | -1.01% |
| Agilent Technologies, Inc.NYSE: A | $43.80B | $155.08 | +0.20% |
| IQVIA Holdings Inc.NYSE: IQV | $43.04B | $261.51 | +0.81% |
| Waters CorporationNYSE: WAT | $40.69B | $414.17 | -0.07% |
Figures last refreshed Aug 18, 2026.